OP-1 for cervical spine fusion: bridging bone in only 1 of 4 rheumatoid patients but prednisolone did not inhibit bone induction in rats.
OP-1 for cervical spine fusion: bridging bone in only 1 of 4 rheumatoid patients but prednisolone did not inhibit bone induction in rats.
复制标题
用于颈椎融合的 OP-1:仅在 4 名类风湿患者中的 1 名中桥接骨,但泼尼松龙不会抑制大鼠的骨诱导。
DOI:
--
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
P. Aspenberg
中科院分区:
文献类型:
--
作者:
C. Jeppsson;H. Säveland;U. Rydholm;P. Aspenberg
We used OP-1 (also called BMP-7) on a collagen type-1 carrier in atlanto-axial posterior fusions to promote bony healing after wire fixation. 4 patients who had instability between the atlas and axis due to rheumatoid disease received the implants. The patients were examined with conventional radiography postoperatively at 2, 6 and 10 months. In 3 patients, no new bone formation was detectable. In 1 patient, new bone bridged the fusion site at 6 months. 3 patients were on chronic steroid treatment, including the patient in whom bone formation was detected. To determine whether steroid treatment could be responsible for the low rate of bone induction, 24 rats each received OP-1 implants in an abdominal muscle pouch. They were divided into 3 groups receiving saline, 0.1 or 1.0 mg/kg BW of prednisolone daily until they were killed 3 weeks postoperatively. Specimens were decalcified for histology and the amount of calcium in the decalcifying solution was measured. All groups showed ossicles induced by OP-1, and no effect of prednisolone was detected. Thus the failures in the patients may have causes other than prednisolone treatment.
影响因子:
1.8
作者:
U. Ripamonti;Barbara Van DenHeever;T. Sampath;M. Tucker;D. Rueger;A. Reddi
通讯作者:
U. Ripamonti;Barbara Van DenHeever;T. Sampath;M. Tucker;D. Rueger;A. Reddi